The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventat...
Citation: The Journal of Headache and Pain 2018 19:91